(Q36154866)

12 August 2017

1 reference

title

Phosphodiesterase 5 inhibitors for erectile dysfunction (English)

1 reference

12 August 2017

Stephen M Setter

1

1 reference

12 August 2017

Jason L Iltz

2

1 reference

12 August 2017

Jack E Fincham

3

1 reference

12 August 2017

R Keith Campbell

4

1 reference

12 August 2017

Danial E Baker

5

1 reference

12 August 2017

language of work or name

English

0 references

publication date

7 June 2005

1 reference

Annals of Pharmacotherapy

12 August 2017

1 reference

12 August 2017

39

1 reference

12 August 2017

1286-1295

1 reference

12 August 2017

7-8

1 reference

Epidemiology of Erectile Dysfunction

12 August 2017

1 reference

Erectile dysfunction and coronary risk factors: prospective results from the Massachusetts male aging study

21 January 2018

1 reference

The mutually reinforcing triad of depressive symptoms, cardiovascular disease, and erectile dysfunction

21 January 2018

1 reference

Drug-induced male sexual dysfunction. An update

21 January 2018

1 reference

Sexual dysfunction in hypertensive men. A critical review of the literature

21 January 2018

1 reference

The impact of first-line antihypertensive drugs on erectile dysfunction

21 January 2018

1 reference

Antipsychotic drug therapy and sexual dysfunction in men.

21 January 2018

1 reference

Overview of phosphodiesterase 5 inhibition in erectile dysfunction

21 January 2018

1 reference

Vardenafil treatment for erectile dysfunction

21 January 2018

1 reference

Review of tadalafil in the treatment of erectile dysfunction

21 January 2018

1 reference

Erectile dysfunction: management update

21 January 2018

1 reference

Novel PDE5 inhibitors for the treatment of male erectile dysfunction

21 January 2018

1 reference

ACC/AHA expert consensus document. Use of sildenafil (Viagra) in patients with cardiovascular disease. American College of Cardiology/American Heart Association

21 January 2018

1 reference

Vardenafil: a review of its use in erectile dysfunction

21 January 2018

1 reference

Sildenafil (Viagra) for the treatment of erectile dysfunction in men with diabetes

21 January 2018

1 reference

2000 ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: a practical summary for emergency physicians

21 January 2018

1 reference

Vardenafil: update on clinical experience

21 January 2018

1 reference

Sildenafil in patients with cardiovascular disease

21 January 2018

1 reference

Cardiovascular effects of tadalafil in patients on common antihypertensive therapies

21 January 2018

1 reference

Cardiovascular effects of tadalafil

21 January 2018

1 reference

Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group

21 January 2018

1 reference

Efficacy, safety, and use of sildenafil in urologic practice

21 January 2018

1 reference

Patient and partner satisfaction with Viagra (sildenafil citrate) treatment as determined by the Erectile Dysfunction Inventory of Treatment Satisfaction Questionnaire

21 January 2018

1 reference

Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. Sildenafil Diabetes Study Group.

21 January 2018

1 reference

Efficacy of sildenafil citrate in treatment of erectile dysfunction: effect of type 2 diabetes

21 January 2018

1 reference

The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial

21 January 2018

1 reference

Efficacy and tolerability of vardenafil for treatment of erectile dysfunction in patient subgroups

21 January 2018

1 reference

Efficacy of vardenafil in men with erectile dysfunction: a flexible-dose community practice study

21 January 2018

1 reference

The efficacy and safety of flexible-dose vardenafil (levitra) in a broad population of European men.

21 January 2018

1 reference

Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial

21 January 2018

1 reference

Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial

21 January 2018

1 reference

Efficacy and treatment satisfaction with on-demand tadalafil (Cialis) in men with erectile dysfunction

21 January 2018

1 reference

Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction

21 January 2018

1 reference

Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study

21 January 2018

1 reference

Effects of tadalafil on erectile dysfunction in men with diabetes

21 January 2018

1 reference

Switching from long-term treatment with self-injections to oral sildenafil in diabetic patients with severe erectile dysfunction

21 January 2018

1 reference

Oral sildenafil in the treatment of erectile dysfunction in diabetic men: a randomized double-blind and placebo-controlled study

21 January 2018

1 reference

Long-term effect of sildenafil citrate on erectile dysfunction after radical prostatectomy: 3-year follow-up.

21 January 2018

1 reference

Efficacy and factors associated with successful outcome of sildenafil citrate use for erectile dysfunction after radical prostatectomy

21 January 2018

1 reference

Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy

21 January 2018

1 reference

Role of Viagra after radical prostatectomy.

21 January 2018

1 reference

Tadalafil in the treatment of erectile dysfunction following bilateral nerve sparing radical retropubic prostatectomy: a randomized, double-blind, placebo controlled trial

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1E487

1 reference

12 August 2017

1 reference